Connect with us

Hi, what are you looking for?

Investing

RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated...

Investing

Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce the fourth and final closing of its non-brokered private placement offering...

Investing

Lahontan Gold Corp. (TSXV:LG)(OTCQB:LGCXF)(FSE:Y2F) (the ‘Company‘ or ‘Lahontan‘) is pleased to announce that the Company has commenced metallurgical test work on gold and silver...

Investing

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the ‘Company’ or ‘Spearmint’) announces that it intends to complete a consolidation of its...